Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SSX4 Antikörper (AA 63-91)

Der Kaninchen Polyklonal Anti-SSX4-Antikörper wurde für WB validiert. Er ist geeignet, SSX4 in Proben von Human zu detektieren.
Produktnummer ABIN657137

Kurzübersicht für SSX4 Antikörper (AA 63-91) (ABIN657137)

Target

Alle SSX4 Antikörper anzeigen
SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

Reaktivität

  • 31
  • 1
Human

Wirt

  • 27
  • 4
Kaninchen

Klonalität

  • 29
  • 2
Polyklonal

Konjugat

  • 14
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SSX4 Antikörper ist unkonjugiert

Applikation

  • 23
  • 18
  • 2
  • 1
  • 1
Western Blotting (WB)

Klon

RB32991
  • Bindungsspezifität

    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 63-91

    Aufreinigung

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This SSX4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 63-91 amino acids from the Central region of human SSX4.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Target

    SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

    Andere Bezeichnung

    SSX4

    Hintergrund

    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.

    Molekulargewicht

    21858

    NCBI Accession

    NP_001030004, NP_001035702, NP_005627, NP_783856

    UniProt

    O60224
Sie sind hier:
Chat with us!